Similar articles

• Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.

  Chatis PA, Miller CH, Schrager LE, Crumpacker CS. Chatis PA, et al. N Engl J Med. 1989 Feb 2;320(5):297-300. doi: 10.1056/NEJM198902023200507. N Engl J Med. 1989. PMID: 2536137 No abstract available.
• [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].

  Jansen CL, Maris-Tegeler WG, Wertheim-van Dillen PM, Frissen PH, Weiland HT, van der Noordaa J. Jansen CL, et al. Ned Tijdschr Geneeskd. 1992 Feb 8;136(6):280-4. Ned Tijdschr Geneeskd. 1992. PMID: 1311058 Dutch.
• The potential of phosphonoformate for the treatment of herpex simplex labialis.

  Oxford J. Oxford J. J Antimicrob Chemother. 1980 Nov;6(6):694-5. doi: 10.1093/jac/6.6.694. J Antimicrob Chemother. 1980. PMID: 6449499 No abstract available.
• [Treatment of cytomegalovirus infections in immunosuppressed patients].

  Michon C, Girard PM, Ngovan P, Simonpoli AM, Le Hoang P. Michon C, et al. Ann Med Interne (Paris). 1988;139(7):511-5. Ann Med Interne (Paris). 1988. PMID: 2854380 Review. French. No abstract available.
• [Resistance of herpes simplex viruses to antiviral drugs].

  Scieux C, Bianchi A. Scieux C, et al. Pathol Biol (Paris). 1993 Feb;41(2):172-7. Pathol Biol (Paris). 1993. PMID: 8392160 Review. French.